Neuronetics, Inc. — Director's Dealing 2018

Jun 28, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Neuronetics, Inc. (STIM)
CIK: 0001227636
Period of Report: 2018-06-27

Reporting Person: Thatcher Christopher (Director, President and CEO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$0.87	2025-02-18	Common Stock (390297)		Direct
Employee Stock Option (Right to Buy)	$0.87	2025-07-14	Common Stock (215074)		Direct
Employee Stock Option (Right to Buy)	$2.32	2027-07-19	Common Stock (115726)		Direct
Employee Stock Option (Right to Buy)	$4.64	2028-03-15	Common Stock (95653)		Direct

Footnotes

F1: Ten percent (10%) of the shares subject to the option vested on February 19, 2015, Twenty-five percent (25%) of the shares subject to the option vested on November 1, 2015, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

F2: Ten percent (10%) of the shares subject to the option vested on July 15, 2015, Twenty-five percent (25%) of the shares subject to the option vested on November 1, 2015, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

F3: Twenty-five percent (25%) of the shares subject to the option shall vest on July 20, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.

F4: Twenty-five percent (25%) of the shares subject to the option shall vest on March 16, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.